Cite
HARVARD Citation
Huang, L. et al. (2019). A phase III clinical trial to evaluate the safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine (PPV23) in healthy children, adults, and elderly. Human vaccines & immunotherapeutics. 15 (1), pp. 249-255. [Online].